AngioDynamics (NASDAQ:ANGO) Releases Earnings Results

AngioDynamics (NASDAQ:ANGO) posted its earnings results on Wednesday. The medical instruments supplier reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.07, RTT News reports. AngioDynamics had a negative net margin of 83.95% and a negative return on equity of 5.86%. The business had revenue of $72.90 million for the quarter, compared to analyst estimates of $70.93 million. During the same period in the prior year, the company posted ($0.05) EPS. The company’s revenue for the quarter was down .1% on a year-over-year basis. AngioDynamics updated its FY 2025 guidance to -0.380–0.340 EPS and its FY25 guidance to ($0.38)-($0.34) EPS.

AngioDynamics Trading Up 37.7 %

Shares of AngioDynamics stock opened at $12.94 on Friday. The firm’s 50-day moving average price is $8.12 and its 200 day moving average price is $7.38. The firm has a market capitalization of $525.80 million, a PE ratio of -2.12 and a beta of 0.59. AngioDynamics has a twelve month low of $5.26 and a twelve month high of $13.13.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. HC Wainwright reiterated a “buy” rating and set a $14.00 price target on shares of AngioDynamics in a research report on Tuesday, December 10th. Canaccord Genuity Group decreased their target price on AngioDynamics from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, October 4th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.